Lv1
10 积分 2025-01-21 加入
Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
11分钟前
求助中
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
4小时前
已关闭
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
4小时前
已完结
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia
4小时前
已完结
HDAC6 as privileged target in drug discovery: A perspective
11小时前
已完结
皖公网安备34019202002308
